Bryostatin Treatment of Moderately Severe Alzheimer's Disease
Public ClinicalTrials.gov record NCT04538066. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Assessing Safety, Tolerability and Long-term Efficacy of Bryostatin in the Treatment of Moderately Severe Alzheimer's Disease Subjects Not Receiving Memantine Treatment
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the safety, tolerability, and long-term efficacy of bryostatin 1 (hereafter referred to as bryostatin) for the treatment of moderately severe Alzheimer's disease (AD).
Study identification
- NCT ID
- NCT04538066
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 122 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 55 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 30, 2020 (Actual)
- Primary completion
- Nov 16, 2022 (Actual)
- Completion
- Nov 16, 2022 (Actual)
- Last update posted
- Jul 31, 2024
2020 – 2022
United States locations
- U.S. sites
- 19
- U.S. states
- 9
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Axiom Research | Colton | California | 92324 | — |
| Pacific Research Network | San Diego | California | 92103 | — |
| JEM Research | Atlantis | Florida | 33462 | — |
| Galiz Research | Hialeah | Florida | 33016 | — |
| ClinCloud | Maitland | Florida | 32751 | — |
| Miami Dade Medical Research Institute | Miami | Florida | 33176 | — |
| Anchor Neuroscience | Pensacola | Florida | 32502 | — |
| Progressive Medical Research | Port Orange | Florida | 32127 | — |
| Alzheimer's Research and Treatment Center | Wellington | Florida | 33414 | — |
| Atlanta Center for Medical Research | Atlanta | Georgia | 30331 | — |
| Columbus Memory Center | Columbus | Georgia | 31909 | — |
| iResearch Atlanta | Decatur | Georgia | 30030 | — |
| iResearch Savannah | Savannah | Georgia | 31405 | — |
| Fort Wayne Neurological Center | Fort Wayne | Indiana | 46804 | — |
| Millenium Psychiatric Associates | St Louis | Missouri | 63132 | — |
| Neurological Associates of Albany, P. C. | Albany | New York | 12208 | — |
| Alzheimer's Research Center | Matthews | North Carolina | 28105 | — |
| Summitt Research Network (Oregon) | Portland | Oregon | 97210 | — |
| Kingfisher Cooperative | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04538066, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 31, 2024 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04538066 live on ClinicalTrials.gov.